Skip to main content

Runway Growth Finance Corp.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

RWAY$6.63+0.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Schedule of Investments as of September 30, 2026 (unaudited)

Consolidated Schedule of Investments (Unaudited)

Portfolio CompanyInvestment TypeInvestment Description(1)(2)(4)Initial Acquisition DateMaturity DatePrincipal ($) /SharesCost ($)Fair Value ($) (3)Footnotes
Non-Control/Non-Affiliate Investments
Debt Investments
Application Software
Airship Group, Inc.Senior SecuredSOFR+3.75%, 9.08% floor, 3.00% PIK, 3.25% ETP6/28/20246/15/202851,81352,19952,668(11) (12) (13)
BlueConic Holding, Inc. (fka Blueshift Labs, Inc.)Second Lien0.00% until 06/17/2028; thereafter, 20.00% PIK6/17/20266/17/203018,50015,45715,990(11) (14)
CarNow, Inc.Senior SecuredSOFR+7.25%, 11.75% floor, 3.10% ETP3/22/20243/22/202920,00018,67418,958(12) (13)
Piano Software, Inc.Senior SecuredSOFR+7.25%, 11.25% floor, 0.50% PIK, 1.50% ETP12/31/202412/31/202943,04542,36842,429(11) (12) (13)
VTX Intermediate Holdings, Inc. (dba VertexOne)Senior SecuredSOFR+7.00%, 10.25% floor, 4.00% ETP12/12/20249/24/202935,50835,60235,888(12) (13) (28)
VTX Intermediate Holdings, Inc. (dba VertexOne)Second LienFIXED 12.50% PIK, 33.50% ETP12/12/20249/24/20297,2807,0737,296(11) (12) (19) (28)
Zinnia Corporate Holdings, LLCSenior SecuredSOFR+6.50%, 8.50% floor9/23/20249/21/202940,00039,47039,556(13)
Total Application Software - 43.01%*210,843212,785
Commercial & Professional Services
Bombora, Inc.Senior SecuredSOFR+4.25%, 6.75% floor, 3.25% PIK, 1.11% ETP12/26/20231/15/202832,17232,30032,498(11) (12) (13)
Elevate Services, Inc.Senior SecuredSOFR+7.50%, 12.78% floor, 0.50% ETP7/10/20237/10/202739,00038,48039,195(12) (13)
Swing Education, Inc.Senior SecuredSOFR+7.00%, 10.80% floor, 5.00% ETP6/27/20256/15/20298,0008,0037,850(12) (13)
Swing Education, Inc. (Revolver)Senior SecuredSOFR+6.65%, 10.45% floor6/27/20256/1/2028-(23)-(13) (26)
Total Commercial & Professional Services - 16.08%*78,76079,543
Consumer Services
Buzz Finco, LLC (dba Bumble)Senior SecuredSOFR+6.75%, 9.25% floor4/24/20264/24/203014,53114,33215,247(10) (15)
FINN GmbHSenior SecuredSOFR+8.75%, 10.75% floor12/8/20256/30/203020,00019,23119,075(6) (10) (13)
Total Consumer Services - 6.94%*33,56334,322
Consumer Staples Distribution & Retail
Marley Spoon SE (Bridge Loan)Senior SecuredSOFR+8.00% PIK, 10.50% floor, 14.00% ceiling9/2/202612/15/20265,5525,5525,564(6) (10) (11) (15) (18) (22) (28)
Marley Spoon SESenior SecuredSOFR+8.00% PIK, 10.50% floor, 14.00% ceiling, 2.00% ETP4/24/202612/31/203017,58317,58317,774(6) (10) (11) (12) (15) (22)
Marley Spoon SESubordinated Debt - Senior Tranche Term LoanSOFR+8.00% PIK, 10.50% floor, 14.00% ceiling, 0.42% ETP4/24/202612/31/203014,46514,46514,530(6) (10) (11) (12) (15) (18) (22) (27)
Marley Spoon SESubordinated Debt - Junior Tranche Term LoanSOFR+8.00% PIK, 10.50% floor, 14.00% ceiling, 2.00% ETP4/24/202612/31/203049,36216,908-(6) (10) (11) (12) (15) (22) (27)
Total Consumer Staples Distribution & Retail - 7.65%*54,50837,868
Portfolio CompanyInvestment TypeInvestment Description(1)(2)(4)Initial Acquisition DateMaturity DatePrincipal ($) /SharesCost ($)Fair Value ($) (3)Footnotes
Non-Control/Non-Affiliate Investments
Debt Investments
Financial Services
Autobooks, Inc.Senior SecuredSOFR+7.50%, 11.77% floor, 3.75% ETP5/5/20252/5/202838,60038,62039,220(12) (13)
Hurricane Cleanco LimitedSenior SecuredFIXED 6.25%, 6.25% PIK12/31/202411/22/202931,50229,97631,188(5) (10) (11) (18)
Under Technologies, Inc. (dba Rho)Senior SecuredSOFR+7.75%, 11.39% floor, 5.00% ETP5/8/20265/8/203120,00019,86819,868(12) (13)
Vesta Payment Solutions, Inc.Senior SecuredSOFR+7.00%, 9.00% floor, 10.00% ETP11/29/202212/16/202625,00026,67022,720(12) (28)
Total Financial Services - 22.84%*115,134112,996
Health Care Equipment & Services
Biotricity, Inc.Senior SecuredSOFR+10.50%, 11.50% floor, 10.29% ETP4/6/20265/15/202713,84613,91213,116(12) (15)
EBR Systems, Inc.Senior SecuredPRIME+4.90%, 8.90% floor, 4.50% ETP6/30/20226/15/202740,00041,22841,526(12) (13) (15)
HR Pharmaceuticals, LLCSenior SecuredSOFR+6.00%, 8.00% floor, 5.36% ETP1/29/20261/29/20316,5466,4636,493(12) (13)
HR Pharmaceuticals, LLC (Revolver)Senior SecuredSOFR+6.00%, 8.00% floor1/29/20261/29/2031206193204
ImpediMed, Inc.Senior SecuredSOFR+9.50%, 13.75% floor, 9.00% ETP4/6/20262/5/203011,50010,92211,421(9) (10) (12) (15)
MedMinder Systems, Inc.Senior SecuredPRIME+4.35%, 9.10% floor, 11.85% ceiling, 6.00% ETP4/6/20268/18/202825,00023,51526,850(12) (13)
Mingle Healthcare Solutions, Inc.Senior SecuredSOFR+9.75%, 12.26% floor, 10.50% ETP8/15/201812/15/20264,1274,7571,885(12) (22)
Triple Ring Technologies, Inc.Senior SecuredSOFR+7.50%, 12.00% floor, 7.75% ETP4/6/202612/6/20288,0007,6617,917(12) (13)
Total Health Care Equipment & Services - 22.12%*108,651109,412
Household & Personal Products
13 Scents Inc. (dba Dossier)Senior SecuredSOFR+6.25%, 7.25% floor4/8/20263/31/203125,40124,98924,989(13)
13 Scents Inc. (dba Dossier) (Revolver)Senior SecuredSOFR+6.25%, 7.25% floor4/8/20263/31/20312,7352,6762,676
Madison Reed, Inc.Senior SecuredPRIME+5.00%, 12.50% floor, 3.00% ETP8/29/20258/29/202940,00039,63439,344(12) (13)
Total Household & Personal Products - 13.55%*67,29967,009
Insurance
Kin Insurance, Inc.Senior SecuredPRIME+5.00%, 12.00% floor, 2.00% ETP8/13/20258/13/202930,00029,53929,875(12) (13)
Kin Insurance, Inc.Senior SecuredPRIME+5.00%, 12.00% floor, 2.00% ETP12/30/20258/13/202915,00014,68714,938(12) (23)
Total Insurance - 9.06%*44,22644,813
Portfolio Company · Investment Type · Investment Description(1)(2)(4) · Initial Acquisition Date · Maturity Date · Principal ($) /Shares · Cost ($) · Fair Value ($) (3) · Footnotes
Non-Control/Non-Affiliate Investments
Debt Investments
Media & Entertainment
Skillshare, Inc.Senior SecuredSOFR+6.75%, 10.96% floor, 2.50% ETP8/15/20252/8/20299,1869,2238,531(12) (13)
Snap! Mobile, Inc.Senior SecuredSOFR+7.50%, 12.10% floor, 3.83% ETP9/30/20249/30/202818,00017,98217,763(12) (13)
Total Media & Entertainment - 5.31%*27,20526,294
Multi-Sector Holdings
SPB C-2024, LLCSenior SecuredFIXED 15.00% PIK, 1.57% ETP12/16/202512/16/202811,03210,99211,119(10) (11) (12)
Total Multi-Sector Holdings - 2.25%*10,99211,119
Pharmaceutical, Biotechnology & Life Sciences
4Web, Inc.Senior SecuredSOFR+9.25%, 12.75% floor, 34.43% ETP4/6/202612/31/202719,30123,05123,721(12) (13)
AOTI, Inc.Senior SecuredSOFR+7.75%, 10.90% floor, 5.60% ETP4/6/20262/15/202919,47818,50519,680(12) (13) (15)
Eton Pharmaceuticals, Inc.Senior SecuredSOFR+6.55%, 9.30% floor, 5.45% ETP4/6/202612/17/202722,00021,86323,409(10) (12) (13) (15)
Goodwin Biotechnology, Inc.Senior SecuredSOFR+9.00%, 13.25% floor, 5.44% ETP4/6/20269/13/20275,6215,4195,558(12) (13)
Journey Medical CorporationSenior SecuredSOFR+7.75%, 12.75% floor, 5.00% ETP4/6/20266/27/202825,00024,10125,327(12) (13) (15)
NeoLight, LLCSenior SecuredPRIME+6.50%, 13.50% floor, 50% Cash/50% PIK, 9.66% ETP4/6/20268/15/20276,1556,1375,608(11) (12) (13)
Nicoya Lifesciences, Inc.Senior SecuredSOFR+9.00%, 12.75% floor, 11.76% ETP4/6/20264/14/20278,5008,6269,008(7) (10) (12) (13)
Shield Therapeutics PLCSenior SecuredSOFR+8.75%, 12.25% floor, 5.00% ETP12/2/20259/28/20285,0004,9095,010(5) (10) (12) (13) (15) (28)
Shield Therapeutics PLCSenior SecuredSOFR+8.75%, 12.25% floor, 6.56% ETP4/6/20269/28/202820,00019,33020,040(5) (10) (12) (13) (15) (28)
Sincerus Pharmaceuticals, Inc.Senior SecuredSOFR+6.75%, 10.50% floor, 8.85% ETP4/6/20268/31/203015,99715,58916,389(12) (13)
Sincerus Pharmaceuticals, Inc.Senior SecuredSOFR+6.75%, 10.50% floor, 7.50% ETP6/30/20268/31/20304,0033,9994,100(12) (13)
Total Pharmaceutical, Biotechnology & Life Sciences - 31.91%*151,529157,850
Systems Software
Circadence CorporationSenior SecuredSOFR+11.00%, 14.69% floor, 10.82% ETP12/20/201812/31/202617,10218,88416,518(12)
Digicert, Inc.Senior SecuredSOFR+5.75%, 6.50% floor7/30/20257/30/20309,2349,1229,060(13)
Digicert, Inc. (Revolver)Senior SecuredSOFR+5.75%, 6.50% floor7/30/20257/30/2030-(7)-(26)
Total Systems Software - 5.17%*27,99925,578
Technology Hardware & Equipment
Brivo, Inc.Senior SecuredSOFR+7.00%, 10.66% floor, 2.53% ETP12/27/202412/15/202940,00040,07941,165(12) (13)
Linxup, LLCSenior SecuredPRIME+3.25%, 11.75% floor, 2.25% ETP11/3/202311/15/202730,00030,28431,118(12) (13)
Total Technology Hardware & Equipment - 14.61%*70,36372,283
Total Debt Investments - 200.50%*1,001,072991,872
Portfolio Company · Investment Type · Investment Description(1)(2)(4) · Initial Acquisition Date · Maturity Date · Principal ($) /Shares · Cost ($) · Fair Value ($) (3) · Footnotes
Non-Control/Non-Affiliate Investments
Equity Investments
Application Software
Aria Systems, Inc.EquitySeries G Preferred Stock7/10/2018N/A289,419250256(14)
VTX Intermediate Holdings, Inc. (dba VertexOne)EquitySeries C Preferred Units12/12/2024N/A3,015,2191439(14)
Total Application Software - 0.05%*393265
Commercial & Professional Services
FiscalNote, Inc.EquityCommon Stock10/19/2020N/A19,2404381(14) (15) (16)
JobGet Holdings, Inc. (fka Snagajob, Inc.)EquitySeries C-1 Preferred Stock11/15/2024N/A476,56439,27516,962(14) (25)
JobGet Holdings, Inc. (fka Snagajob, Inc.)EquitySeries C-2 Preferred Stock11/15/2024N/A16,963--(14) (25)
Total Commercial & Professional Services - 3.43%*39,71316,963
Consumer Staples Distribution & Retail
Marley Spoon SEEquityCommon Stock7/7/2023N/A46,0044103(6) (10) (14) (15) (16) (18)
Total Consumer Staples Distribution & Retail - 0.00%*4103
Health Care Equipment & Services
CareCloud, Inc.Equity8.75% Series A Cumulative Redeemable Perpetual Preferred Stock1/8/2020N/A462,06412,1329,900(15) (16)
Epica International, Inc.EquityCommon Stock1/4/2022N/A25,000136141(14)
HR Pharmaceuticals, LLCEquityPreferred Units1/29/2026N/A2,000,0002,0001,983(14) (25)
MolecuLight, Inc.EquitySeries B-3 Preferred Stock1/1/2025N/A250,00037-(7) (10) (14) (18) (25)
Total Health Care Equipment & Services - 2.43%*14,30512,024
Media & Entertainment
Minute Media Inc.EquityPreferred Stock12/13/2023N/A1,21912079(5) (10) (14)
Minute Media Inc.EquityCommon Stock12/13/2023N/A160167(5) (10) (14)
Total Media & Entertainment - 0.02%*13686
Pharmaceutical, Biotechnology & Life Sciences
AOTI, Inc.EquityCommon Stock6/30/2024N/A402,634178695(14) (15) (18)
Sincerus Pharmaceuticals, Inc.EquityCommon Stock5/21/2021N/A26,575509445(14)
Total Pharmaceutical, Biotechnology & Life Sciences - 0.23%*6871,140
Total Equity Investments - 6.16%*55,64430,481
Portfolio Company · Investment Type · Investment Description(1)(2)(4) · Initial Acquisition Date · Maturity Date · Principal ($) /Shares · Cost ($) · Fair Value ($) (3) · Footnotes
Non-Control/Non-Affiliate Investments
Warrants & Other Contractual Rights
Application Software
3DNA Corp. (dba NationBuilder)WarrantSeries C-1 Preferred Stock12/28/201812/28/2028273,164104-(14)
Airship Group, Inc.WarrantSeries F Preferred Stock6/28/20246/28/2034519,313414510(14)
Aria Systems, Inc.WarrantSeries G Preferred Stock6/29/20186/29/20282,387,7051,048833(14)
CarNow, Inc.WarrantCommon Stock3/22/20243/22/2034200,0002,4001,822(14)
CarNow, Inc.WarrantCommon Stock4/24/20264/24/203620,000-182(14)
Exeevo, Inc.Contractual RightGross Margin Earnout11/13/20249/30/2027N/A409492(14) (17) (25)
INRIX, Inc.WarrantCommon Stock7/26/20197/26/2029150,804522-(14)
JWP Holdco LLC (fka Longtail Ad Solutions, Inc.)WarrantCommon Units12/12/201912/12/2029167,82747-(14)
Piano Software, Inc.WarrantSeries D Preferred Stock12/31/202412/31/2034119,978348461(14)
Predactiv, Inc. (fka Sharethis, Inc.)WarrantSeries D-3 Preferred Stock12/3/201812/3/2028647,6152,162-(14)
Total Application Software - 0.87%*7,4544,300
Commercial & Professional Services
AllClear ID, Inc.WarrantCommon Stock8/31/20178/31/2027870,5141,750-(14)
Bombora, Inc.WarrantCommon Stock3/31/20213/31/2031121,581174148(14)
Bombora, Inc.WarrantCommon Stock12/26/202312/26/203357,7505170(14)
CloudPay, Inc.WarrantSeries B Preferred Stock6/30/20206/30/203011,273218854(5) (10) (14)
CloudPay, Inc.WarrantSeries D Preferred Stock8/17/20218/17/20313,5025218(5) (10) (14)
CloudPay, Inc.WarrantSeries D Preferred Stock9/26/20229/26/20325,252176103(5) (10) (14)
Elevate Services, Inc.WarrantSeries C Preferred Stock7/10/20237/10/2033248,997447379(14)
Elevate Services, Inc.WarrantSeries C Preferred Stock7/17/20247/17/2034236,549377621(14)
FiscalNote, Inc.Contractual RightEarnout7/29/20227/29/2027N/A127-(14) (15) (17)
JobGet Holdings, Inc. (fka Snagajob, Inc.)WarrantSeries B-1 Preferred Stock9/29/20219/29/2031763,269343-(14)
Swing Education, Inc.WarrantSeries C Preferred Stock6/27/20256/27/2035196,160192(14)
Total Commercial & Professional Services - 0.45%*3,7342,195
Consumer Services
FINN GmbHWarrantSeries C2 Preferred Stock12/4/202512/4/2030385691550(6) (10) (14) (18) (24)
FINN GmbHWarrantSeries C2 Preferred Stock3/10/202612/4/2030201-1,274(6) (10) (14) (18) (24)
Total Consumer Services - 0.37%*6911,824
Consumer Staples Distribution & Retail
Marley Spoon SEWarrantCommon Stock4/25/202612/31/20355,466--(6) (10) (14) (15) (18)
Total Consumer Staples Distribution & Retail - 0.00%* · - · -
Financial Services
Autobooks, Inc.Contractual RightSuccess Fee5/5/2025N/AN/A489694(14) (17)
Betterment Holdings, Inc.WarrantCommon Stock10/6/202310/6/20337,6803538(14)
Betterment Holdings, Inc.WarrantCommon Stock10/6/202310/6/20339,8184041(14)
Credit Sesame, Inc.WarrantCommon Stock1/7/20201/7/2030191,601425191(14)
Under Technologies, Inc. (dba Rho)WarrantSeries B Preferred Stock5/8/20265/8/2036101,20326(14) (25)
Total Financial Services - 0.20%*991970
Portfolio Company · Investment Type · Investment Description(1)(2)(4) · Initial Acquisition Date · Maturity Date · Principal ($) /Shares · Cost ($) · Fair Value ($) (3) · Footnotes
Non-Control/Non-Affiliate Investments
Warrants & Other Contractual Rights
Health Care Equipment & Services
Allurion Technologies, Inc.WarrantCommon Stock3/30/20213/30/20315,320282-(14) (15)
Allurion Technologies, Inc.WarrantCommon Stock6/14/20223/30/20311,851141-(14) (15)
Allurion Technologies, Inc.WarrantCommon Stock9/15/20229/15/20321,850144-(14) (15)
Allurion Technologies, Inc.Contractual RightEarnout8/2/20238/1/2028N/A--(14) (15) (17)
Best ABT, Inc.Contractual RightSettlement Payment Right11/12/20183/31/2027N/A452579(14) (25)
Biotricity, Inc.WarrantSeries A Preferred Stock12/21/202112/21/20289,589-2(14) (15)
Biotricity, Inc.WarrantSeries B Preferred Stock11/11/202411/11/203154,3007-(14) (15)
Biotricity, Inc.WarrantSeries C Preferred Stock8/25/20238/25/2030600,000112-(14) (15)
Biotricity, Inc.WarrantSeries E Preferred Stock12/12/202512/12/2032120,000241(14) (15)
DxTerity Diagnostics, Inc.WarrantSeries B Preferred Stock4/6/201512/31/20262,019,23143-(14)
EBR Systems, Inc.Contractual RightSuccess Fee6/30/20226/30/2032N/A605503(14) (15) (17)
Elutia, Inc.WarrantCommon Stock8/10/20228/10/2029187,970499(14) (15)
Epica International, Inc.WarrantCommon Stock7/24/20187/24/2027581,8181,1891,171(14)
Flowonix Medical, Inc.Contractual RightRoyalty6/26/2023N/AN/A4,6934,284(14)
Ideal Implant, Inc.Contractual RightRoyalty8/1/20232/1/2039N/A1,8061,249(14)
ImpediMed, Inc.WarrantCommon Stock2/6/20252/6/203218,737,80511517(9) (10) (14) (15) (18)
MedMinder Systems, Inc.WarrantSeries C Preferred Stock8/18/20228/18/202965,0925647(14)
Mingle Healthcare Solutions, Inc.WarrantSeries CC Preferred Stock8/15/20188/15/20281,770,973492-(14)
MolecuLight, Inc.WarrantCommon Stock1/1/202512/28/2028394,3223-(7) (10) (14) (18)
Moximed, Inc.WarrantSeries C Preferred Stock6/24/20226/24/2032214,28517539(14)
Onward Medical, N.V.WarrantCommon Stock6/28/20249/26/2034165,33834066(8) (10) (14) (15) (18)
Route 92 Medical, Inc.Contractual RightSuccess Fee3/31/20253/31/2035N/A833706(14) (17)
SetPoint Medical CorporationWarrantSeries B Preferred Stock6/29/20216/29/2031400,0001496(14)
SetPoint Medical CorporationWarrantSeries B Preferred Stock12/29/202212/29/2032600,00074145(14)
Total Health Care Equipment & Services - 1.80%*11,6498,914
Portfolio Company · Investment Type · Investment Description(1)(2)(4) · Initial Acquisition Date · Maturity Date · Principal ($) /Shares · Cost ($) · Fair Value ($) (3) · Footnotes
Non-Control/Non-Affiliate Investments
Warrants & Other Contractual Rights
Household & Personal Products
Madison Reed, Inc.Contractual RightSuccess Fee8/29/2025N/AN/A404464(14) (17)
Total Household & Personal Products - 0.09%*404464
Insurance
Kin Insurance, Inc.WarrantSeries D-3 Preferred Stock9/26/20229/26/203262,364426568(14)
Kin Insurance, Inc.WarrantSeries E Preferred Stock8/13/20258/13/203510,6185461,215(14)
Total Insurance - 0.36%*9721,783
Media & Entertainment
Minute Media Inc.Contractual RightSAFE7/28/2026N/AN/A22(5) (10) (14)
Skillshare, Inc.Contractual RightSuccess Fee8/15/2025N/AN/A33787(14) (17)
Snap! Mobile, Inc.WarrantSeries B Preferred Stock9/30/20249/30/203419,140345294(14)
Total Media & Entertainment - 0.08%*684383
Pharmaceutical, Biotechnology & Life Sciences
4Web, Inc.WarrantSeries D Preferred Stock6/3/20199/3/2031780,3873,9893,665(14)
Goodwin Biotechnology, Inc.WarrantSeries C Preferred Stock9/13/20239/13/2030211,4425054(14) (25)
Insite Vision, Inc.Contractual RightRoyalty4/2/2013N/AN/A--(14) (25)
Mustang Bio, Inc.WarrantCommon Stock3/4/20223/4/2032997315-(14) (15)
NeoLight, LLCWarrantSeries B-2 Preferred Stock2/17/20232/17/2030105,04833(14)
Nicoya Lifesciences, Inc.WarrantSeries B-1 Preferred Stock10/13/202310/13/2030117,30515416(7) (10) (14) (18)
Nicoya Lifesciences, Inc.WarrantSeries A-3 Preferred Stock5/27/20255/27/2032276,63021-(7) (10) (14) (18)
Shield Therapeutics PLCWarrantCommon Stock12/2/202512/2/2031906,4686328(5) (10) (14) (15) (18)
Shield Therapeutics PLCWarrantCommon Stock10/2/202310/2/20298,910,540531100(5) (10) (14) (15) (18)
Shield Therapeutics PLCWarrantCommon Stock6/8/20266/8/20321,765,0196763(5) (10) (14) (15) (18)
Zevra Therapeutics, Inc. (fka Acer Therapeutics, Inc.)Contractual RightContingent Value Right11/17/2023N/AN/A--(10) (14) (15) (25)
Total Pharmaceutical, Biotechnology & Life Sciences - 0.79%*5,1933,929
Portfolio Company · Investment Type · Investment Description(1)(2)(4) · Initial Acquisition Date · Maturity Date · Principal ($) /Shares · Cost ($) · Fair Value ($) (3) · Footnotes
Non-Control/Non-Affiliate Investments
Warrants & Other Contractual Rights
Systems Software
Circadence CorporationWarrantSeries B Preferred Stock12/20/201812/20/20281,538,4623,630-(14)
Circadence CorporationWarrantSeries B Preferred Stock10/31/201910/31/2029384,615846-(14)
Circadence CorporationContractual RightSuccess Fee12/21/2023N/AN/A304219(14) (17)
Scale Computing, Inc.WarrantCommon Stock3/29/20193/29/20299,665,667346-(14)
Synack, Inc.WarrantCommon Stock12/29/20236/30/2032131,521168128(14)
Total Systems Software - 0.07%*5,294347
Technology Hardware & Equipment
Brivo, Inc.WarrantSeries A-2 Preferred Stock10/20/202210/20/2032201,00098226(14)
Brivo, Inc.WarrantSeries A-2 Preferred Stock12/27/202412/27/203432,1094356(14)
Dejero Labs, Inc.WarrantCommon Stock5/31/20195/31/2029333,621192250(7) (10) (14) (18)
Linxup, LLCContractual RightSuccess Fee11/3/202311/3/2033N/A253650(14) (17)
RealWear, Inc.WarrantCommon Stock10/5/201810/5/2028112,4511364(14)
RealWear, Inc.WarrantCommon Stock12/28/201812/28/202822,491251(14)
RealWear, Inc.WarrantCommon Stock6/27/20196/27/2029123,8943815(14)
Total Technology Hardware & Equipment - 0.24%*1,1281,192
Total Warrants & Other Contractual Rights - 5.32%*38,19426,301
Total Non-Control/Non-Affiliate Investments - 211.98%*1,094,9101,048,654
Portfolio Company · Investment Type · Investment Description(1)(2)(4) · Initial Acquisition Date · Maturity Date · Principal ($) /Shares · Cost ($) · Fair Value ($) (3) · Footnotes
Affiliate Investments(20)
Equity Investments
Application Software
Coginiti CorpEquityCommon Stock3/9/2020N/A1,040,1604,551-(14)
Total Application Software - 0.00%*4,551-
Total Equity Investments - 0.00%*4,551-
Warrants & Other Contractual Rights
Application Software
Coginiti CorpWarrantCommon Stock3/9/20203/9/2030811,770--(14)
Total Application Software - 0.00%* · - · -
Total Warrants & Other Contractual Rights - 0.00%* · - · -
Total Affiliate Investments - 0.00%*4,551-
Control Investments(21)
Equity Investments
Multi-Sector Holdings
Runway-Cadma I LLCEquity50% Equity Interest3/6/2024N/AN/A12,18012,876(10)
Total Multi-Sector Holdings - 2.60%*12,18012,876
Total Equity Investments - 2.60%*12,18012,876
Total Control Investments - 2.60%*12,18012,876
Total Investments - 214.58%*$1,111,641$1,061,530
Cash and Cash Equivalents and Short Term Investments
Goldman Sachs Financial Square Government Fund Institutional SharesFGTXX/38141W2732,4972,497
Cash1,1221,122
Total Cash and Cash Equivalents and Short Term Investments - 0.73%*3,6193,619
Total Investments, Cash and Cash Equivalents, and Short Term Investments - 215.31%*$1,115,260$1,065,149
(1)Disclosures of interest rates on notes include cash interest rates and payment-in-kind ("PIK") interest rates, as applicable. Unless otherwise indicated, all of the Company's variable interest debt instruments bear interest at a rate determined by reference to the U.S. Prime Rate ("PRIME") or the 1-month or 3-month Secured Overnight Financing Rate ("SOFR"). At September 30, 2026, the U.S. PRIME Rate was 7.00%, the 1-Month SOFR was 3.91%, and the 3-Month SOFR was 4.08%.
(2)The Company’s investments are generally acquired in private transactions exempt from registration under the Securities Act of 1933, as amended (the "Securities Act"), and, therefore, except as otherwise noted, are subject to limitation on resale, may be deemed to be "restricted securities" under the Securities Act, and were valued at fair value as determined in good faith by the Board of Directors (as defined in "Note 2 – Summary of Significant Accounting Policies").
(3)Investments are held at Fair Value net of the Fair Value of Unfunded Commitments. Refer to "Note 8 – Commitments, Contingencies, and Off-Balance Sheet Arrangements" for additional detail.
(4)All portfolio companies are domiciled in the United States, unless otherwise noted.
(5)Portfolio company is domiciled in the United Kingdom. Fair value of United Kingdom domiciled investments represents 11.62% of net assets.
(6)Portfolio company is domiciled in Germany. Fair value of German domiciled investments represents 11.88% of net assets.
(7)Portfolio company is domiciled in Canada. Fair value of Canadian domiciled investments represents 1.87% of net assets.
(8)Portfolio company is domiciled in the Netherlands. Fair value of Dutch domiciled investments represents 0.01% of net assets.
(9)Portfolio company is domiciled in Australia. Fair value of Australian domiciled investments represents 2.31% of net assets.
(10)Investment is not a qualifying investment as defined under Section 55(a) of the Investment Company Act of 1940, as amended. The fair value of non-qualifying assets represents 18.48% of total assets as of September 30, 2026. Qualifying assets must represent at least 70% of total assets at the time of acquisition of any additional non-qualifying assets. If at any time qualifying assets do not represent at least 70% of the Company's total assets, the Company will be precluded from acquiring any additional non-qualifying assets until such time as it complies with the requirements of Section 55(a).
(11)Represents a PIK security. PIK interest will be accrued and paid at maturity.
(12)Disclosures of end-of-term payments ("ETP") are one-time payments stated as a percentage of principal amount.
(13)The investment is an eligible loan investment in the collateral under the Credit Facility (as defined in "Note 7 – Borrowings").
(14)Investments are non-income producing.
(15)Portfolio company is a publicly traded company whose securities are listed on a national securities exchange.
(16)Investment is not a "restricted security" under the Securities Act.
(17)Investment is either a cash success fee payable or earnout of shares based on the consummation of certain trigger events.
(18)Investment is denominated in a foreign currency. At each balance sheet date, portfolio company investments denominated in foreign currencies are translated into U.S. dollars using the spot exchange rate on the last business day of the period. Transactions of foreign portfolio company investments, and income related from such investments, are translated into U.S. dollars using relevant rates of exchange on the respective dates of such transactions.
(19)Investment represents a security with a tiered fee that increases over time, dependent upon the timing of repayment. Such fees are recorded in "Interest income" on the Consolidated Statements of Operations.
(20)Affiliate portfolio company as defined under the 1940 Act in which the Company owns between 5% and 25% (inclusive) of the investment's voting securities and does not have rights to maintain greater than 50% representation on the board.
(21)Control portfolio company, as defined under the 1940 Act, in which the Company owns more than 25% of the investment’s voting securities or has greater than 50% representation on its board.
(22)Investment is on non-accrual status as of September 30, 2026 and is therefore considered non-income producing.
(23)The Company sold a participation representing $15.0 million of the aggregate outstanding principal balance of the portfolio company's senior secured loan. As the transfer did not meet the requirements for sale accounting under ASC 860, the Company recorded a corresponding secured borrowing, measured at fair value and included in "Secured borrowings" on the Consolidated Statements of Assets and Liabilities. See "Note 2 – Summary of Significant Accounting Policies, Secured Borrowings" for additional detail.
(24)Number of shares is not fixed and is based on a percentage of the portfolio company’s fully diluted share capital as of September 30, 2026.
(25)Transfers are subject to contractual restrictions contained in the issuer’s governing documents and other applicable agreements, including rights of first refusal and other limitations on transfer.
(26)No borrowings were outstanding under the revolving loan commitment as of September 30, 2026. The negative cost represents unamortized original issue discount and other fees received in connection with the commitment.
(27)This position is convertible debt. It bears interest at a contractual rate equal to SOFR plus a spread of 8.00% (subject to a 10.50% floor and 14.00% ceiling) and matures December 31, 2030. The Company, as Lender, holds the sole right to convert all or a portion of the outstanding obligations into common shares of the borrower group's intermediate parent at a fixed price of EUR 1.00 per share, subject to an 80% aggregate ownership cap. Effective March 31, 2026, the Company placed this position on non-accrual status; interest income and original issue discount accretion are not being recorded on this position for financial reporting purposes. For more information, refer to "Note 2 – Summary of Significant Accounting Policies, Non-Accrual Investments".
(28)The maturity date shown is subject to change upon the satisfaction, or failure, of certain conditions specified in the credit agreement, including milestones, extension conditions, or the maturity of other indebtedness of the portfolio company.
*Fair value as a percentage of net assets.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.